.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01C_SpecificAntirheumaticAgents.M01CB02_SodiumAurotiosulfate.SodiumAurotiosulfate .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01C_SpecificAntirheumaticAgents.M01CB02_SodiumAurotiosulfate.SodiumAurotiosulfate| name: | SodiumAurotiosulfate |
| ATC code: | M01CB02 | route: | intramuscular |
| n-compartments | 2 |
Sodium aurotiosulfate is a gold(I)-containing compound that was historically used as an antirheumatic agent, primarily for the treatment of rheumatoid arthritis. It functions as a disease-modifying antirheumatic drug (DMARD). Its use today is generally obsolete and has been replaced by better-tolerated and more effective agents.
No primary pharmacokinetic studies on sodium aurotiosulfate in humans are available in biomedical literature. Thus, all pharmacokinetic parameters below are estimated based on analogies with other gold-based DMARDs such as sodium aurothiomalate and provided for reference only.